Concurrent high dose radiotherapy and cisplatinum-based chemotherapy ± immunotherapy versus radiotherapy alone in esophageal carcinoma.: Molecular biology in assesment of response to chemoradiotherapy

被引：0
|
作者：
Ibrahim, SM
Ali, AK
Faraag, AA
Hamed, SE
Hafeez, ZMA
机构：
[1] Ain Shams Univ, Dept Radiat Oncol & Nucl Med, Fac Med, Cairo, Egypt
[2] Ain Shams Univ, Biochem & Tumor Biol Dept, Fac Med, Cairo, Egypt
[3] Ain Shams Univ, Dept Surg, Fac Med, Cairo, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80953-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
525
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 36 条
  • [1] Efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma
    任雪姣
    China Medical Abstracts(Internal Medicine), 2019, 36 (03) : 165 - 166
  • [2] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus chemoradiotherapy alone or radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Iocca, O.
    Ferraro, E.
    Gadaleta-Caldarola, G.
    Brandi, M.
    Filippelli, G.
    Infusino, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 69 - 69
  • [3] Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma
    Masao, M
    Yasumasa, K
    Yosiaki, O
    Koichi, K
    Eisaku, Y
    Fusako, K
    Kiyoshi, H
    Satoru, M
    Hiroshi, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 280 - 280
  • [4] Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma
    Murakami, M
    Kuroda, Y
    Okamoto, Y
    Kono, K
    Yoden, E
    Kusumi, F
    Hajiro, K
    Matsusue, S
    Takeda, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (05): : 1049 - 1059
  • [5] Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
    Nayan, Navin
    Bhattacharyya, M.
    Jagtap, Vikas K.
    Kalita, A. K.
    Sunku, R.
    Roy, P. S.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 27 - 30
  • [6] Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting
    Li, Li-Qing
    Fu, Qing-Guo
    Zhao, Wei-Dong
    Wang, Yu-Dan
    Meng, Wan-Wan
    Su, Ting-Shi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis
    Li, Chen
    Tan, Lijun
    Liu, Xiao
    Wang, Xin
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Liang, Jun
    Lv, Jima
    Wang, Xiaozhen
    Bi, Nan
    Deng, Lei
    Wang, Wenqing
    Zhang, Tao
    Ni, Wenjie
    Chang, Xiao
    Han, Weiming
    Gao, Linrui
    Wang, Shijia
    Xiao, Zefen
    THORACIC CANCER, 2021, 12 (12) : 1831 - 1840
  • [8] Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: "High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis"
    Chow, Ronald
    Lock, Michael
    Lee, Sangjune Laurence
    Lo, Simon S. S.
    Simone, Charles B., II
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer
    Suh, Yang-Gun
    Lee, Ik Jae
    Koom, Wong Sub
    Cha, Jihye
    Lee, Jong Young
    Kim, Soo Kon
    Lee, Chang Geol
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (06) : 534 - 540
  • [10] High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
    Sun, Xin
    Wang, Lei
    Wang, Yang
    Kang, Jingjing
    Jiang, Wei
    Men, Yu
    Hui, Zhouguang
    FRONTIERS IN ONCOLOGY, 2020, 10
1234